Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites.

Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, H-7643 Pécs, Hungary.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (Impact Factor: 2.71). 04/2002; 131(3):355-65. DOI: 10.1016/S1532-0456(02)00018-2
Source: PubMed

ABSTRACT In most mammalian species, inorganic arsenicals are extensively biotransformed and excreted both in unchanged form and as metabolites. In the bile of rats receiving arsenate (AsV) or arsenite (AsIII) we have identified monomethylarsonous acid (MMAsIII), purportedly the most toxic metabolite of inorganic arsenic. As rats are not commonly accepted for studying arsenic metabolism, we carried out a comparative investigation on the excretion of AsV, AsIII and their metabolites in five animal species in order to determine whether they also form MMAsIII from AsV and AsIII. Anaesthetised bile duct-cannulated rats, mice, hamsters, rabbits, and guinea pigs were injected with AsV or AsIII (50 micromol/kg, i.v.) and their bile and urine was collected for 2 h. Arsenic in bile and urine was speciated by HPLC-hydride generation-atomic fluorescence spectrometry and the excretion rates of AsV, AsIII, monomethylarsonic acid (MMAsV), MMAsIII and dimethylarsinic acid (DMAsV) were quantified. All species injected with AsV excreted arsenic preferentially into urine, whereas all animals receiving AsIII, except rabbits, delivered more arsenic into bile than urine. Bile contained almost exclusively trivalent arsenic (i.e. AsIII and/or MMAsIII), whereas AsV, AsIII and DMAsV appeared in urine. Except for guinea pigs, which do not methylate arsenic, the other species formed MMAsIII and excreted it into bile. Having excreted as much as 8% of the dose of AsIII or AsV in 2 h as MMAsIII, rats were by far the most efficient producers of this supertoxic metabolite. Thus, although the rat is not a good model for studying long-term arsenic disposition, this species appears especially valuable in studies on AsIII methyltransferase and in vivo formation of MMAsIII.

  • [Show abstract] [Hide abstract]
    ABSTRACT: We evaluated whether the nanoformulation of curcumin could be more effective than free curcumin against arsenic-induced immune dysfunction in rats. Curcumin was encapsulated in polylactic-co-glycolic acid (PLGA). Nanocurcumin (CUR-NP) exhibited a spherical shape with the mean particle size of 130.8nm. Rats were randomly divided into five groups of six each. Group I was kept as the control. In Group II, rats were exposed to sodium arsenite (25ppm) daily through drinking water for 42days. Groups III, IV and V were treated with arsenic as in Group II, however, they were administered with nanoparticle, curcumin (100mg/kgbw) and CUR-NP (100mg/kgbw), respectively, by oral gavage during the last 14days of arsenic exposure. At term, serum and spleen were collected. Immune dysfunction was evaluated by assessing cellular and humoral immunities. Arsenic significantly decreased the splenic lymphocyte proliferation in response to the antigen - Keyhole Limpet Hemocyanin (KLH) and mitogen - concanavalin-A. Arsenic reduced both the delayed type hypersensitivity response and secondary antibody (IgG) response to KLH. It also reduced the lipopolysaccharide-stimulated nitric oxide production in splenic lymphocytes. Free curcumin and CUR-NP treatment significantly attenuated these arsenic-mediated effects. However, the magnitude of the effects indicates that CUR-NP has better ameliorative potential than free curcumin at the equivalent dose level.
    International immunopharmacology 06/2013; · 2.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Arsenic, the environmental metalloid toxicant, is known to induce oxidative damage to liver and produce hepatic fibrosis. The theme of our study was to optimize and evaluate the therapeutic efficacy of galactosylated liposomal flavonoidal antioxidant, quercetin (QC), in combating arsenic-induced hepatic fibrogenesis. The rats of the hepatic damage group were injected s.c. a single dose of sodium arsenite (NaAsO(2)) (100.06 microM/kg b. wt. in 0.5 ml of physiological saline). Hepatocytes and stellate cells were separated. Mitochondrial membranes were isolated from all those separated cells. Oxidative damage was monitored at different isolated subcellular parts of different hepatic cells. Liver fibrosis was also induced by the injection of NaAsO(2). Galactosylated liposomal QC injection before NaAsO(2) treatment checked fibrogenesis completely by protecting the liver from oxidative attack in cellular and subcellular levels. The maximal protections from hepatocellular and fatty metamorphosis, necrosis, Kupffer cell hyperplasia, fibrosis, and in the deposition of collagen contents were observed and reconfirmed by our histopathological and histochemical analysis when rats were treated with galactosylated liposomal QC before NaAsO(2) injection. Application of galactosylated liposomal QC may be a potent therapeutic approach for NaAsO(2)-induced fibrogenesis through a complete protection against oxidative attack in cellular and subcellular parts of rat liver.
    Journal of Pharmacology and Experimental Therapeutics 04/2007; 320(3):994-1001. · 3.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Arsenic (As) speciation in edible seaweed has received a considerable research interest due to its impact on the food safety and human health. In this paper, we developed a simple and cost-effective methodology to extract, separate, and analyze As species in Porphyra samples collected from Jiangsu, Zhejiang, and Shandong provinces of China. Four extraction methods were compared in terms of extraction efficiency and resolution of As species. Microwave-assisted water extraction was chosen due to its short time (5 min) and high efficiency (93% of total As extracted). Total As concentration in the Porphyra samples varied within 14.0–42.1 µg g−1, determined by inductively coupled plasma-atomic emission spectrometry (ICP-AES) after acid digestion. Five As species were determined by high performance liquid chromatography—ultraviolet photo-oxidation—hydride generation—atomic fluorescence spectrometry (HPLC–(UV)–HG–AFS). DMA was found only in one sample with the concentration of 0.67 µg g−1. No As(III), As(V), MMA, and AsB were detected. Taken together, the As speciation results suggest that the risk associated with As in Porphyra to human health may be negligible.
    Analytical Letters 01/2013; 46(10). · 0.97 Impact Factor


Available from
May 19, 2014